ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments
NCT04212702
·
clinicaltrials.gov ↗
UNKNOWN
Status
123
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
DRUG:
Hormonal therapy-based treatments
Sponsor
National Taiwan University Hospital
Collaborators
[object Object]